Rare mutations in the insulin receptor protein coding sequence can give rise to severe growth defects and insulin resistance [10,11], while changes in the expression and regulation of INSR can affect overall signalling and has been associated with diabetes, cancer, and neurodegenerative diseases [12–16]. Here, INSR is linked to cancer.